Top

Current Neurology and Neuroscience Reports

Published in:

01-03-2022 | Stroke | Stroke (B. Ovbiagele, Section Editor)

The Allure of Big Data to Improve Stroke Outcomes: Review of Current Literature

Authors: Muideen T. Olaiya, Nita Sodhi-Berry, Lachlan L. Dalli, Kiran Bam, Amanda G. Thrift, Judith M. Katzenellenbogen, Lee Nedkoff, Joosup Kim, Monique F. Kilkenny

Published in: Current Neurology and Neuroscience Reports | Issue 3/2022

Abstract

Purpose of Review

To critically appraise literature on recent advances and methods using “big data” to evaluate stroke outcomes and associated factors.

Recent Findings

Recent big data studies provided new evidence on the incidence of stroke outcomes, and important emerging predictors of these outcomes. Main highlights included the identification of COVID-19 infection and exposure to a low-dose particulate matter as emerging predictors of mortality post-stroke. Demographic (age, sex) and geographical (rural vs. urban) disparities in outcomes were also identified. There was a surge in methodological (e.g., machine learning and validation) studies aimed at maximizing the efficiency of big data for improving the prediction of stroke outcomes. However, considerable delays remain between data generation and publication.

Summary

Big data are driving rapid innovations in research of stroke outcomes, generating novel evidence for bridging practice gaps. Opportunity exists to harness big data to drive real-time improvements in stroke outcomes.

Available only for authorised users

Feigin VL, Stark BA, Johnson CO, Roth GA, Bisignano C, Abady GG, et al. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden Of Disease Study 2019. The Lancet Neurology. 2021;20(10):795–820.

Donkor ES. Stroke in the 21(st) century: a snapshot of the burden, epidemiology, and quality of life. Stroke Res Treat. 2018;2018:3238165. https://doi.org/10.1155/2018/3238165.CrossRefPubMedPubMedCentral

Paige E, Doyle K, Jorm L, Banks E, Hsu MP, Nedkoff L, et al. A versatile big data health system for Australia: driving improvements in cardiovascular health. Heart Lung Circ. 2021;30(10):1467–76. https://doi.org/10.1016/j.hlc.2021.04.023.CrossRefPubMed

Ung D, Kim J, Thrift AG, Cadilhac DA, Andrew NE, Sundararajan V, et al. Promising use of big data to increase the efficiency and comprehensiveness of stroke outcomes research. Stroke. 2019;50(5):1302–9. https://doi.org/10.1161/STROKEAHA.118.020372.CrossRefPubMed

Olaronke I, Oluwaseun O, editors. Big data in healthcare: prospects, challenges and resolutions. 2016 Future Technologies Conference (FTC); 2016 6–7 Dec. 2016.

Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (nos) for assessing the quality of nonrandomised studies in meta-analyses 2013 [Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.

Andreu-Perez J, Poon CC, Merrifield RD, Wong ST, Yang GZ. Big data for health. IEEE J Biomed Health Inform. 2015;19(4):1193–208. https://doi.org/10.1109/JBHI.2015.2450362.CrossRefPubMed

• Chaudhary D, Khan A, Gupta M, Hu Y, Li J, Abedi V, et al. Obesity and mortality after the first ischemic stroke: is obesity paradox real? PLoS ONE. 2021;16(2):e0246877. https://doi.org/10.1371/journal.pone.0246877. Being overweight or obese was associated with a reduced risk of 1-year mortality after stroke, the mechanisms of which are unclear.CrossRefPubMedPubMedCentral

Gattellari M, Goumas C, Jalaludin B, Worthington J. The impact of disease severity adjustment on hospital standardised mortality ratios: results from a service-wide analysis of ischaemic stroke admissions using linked pre-hospital, admissions and mortality data. PLoS ONE. 2019;14(5):e0216325. https://doi.org/10.1371/journal.pone.0216325.CrossRefPubMedPubMedCentral

10.

Ingrid L, von Euler M, Sunnerhagen KS. Association of prestroke medicine use and health outcomes after ischaemic stroke in Sweden: a registry-based cohort study. BMJ Open. 2020;10(3):e036159. https://doi.org/10.1136/bmjopen-2019-036159.CrossRefPubMedPubMedCentral

11.

•• Kapral MK, Kurdyak P, Casaubon LK, Fang J, Porter J, Sheehan KA. Stroke care and case fatality in people with and without schizophrenia: a retrospective cohort study. BMJ Open. 2021;11(6):e044766. https://doi.org/10.1136/bmjopen-2020-044766. The authors provided evidence that patients with stroke and comorbid schizophrenia had an elevated risk of death from both stroke-related and other causes than those without schizophrenia.CrossRefPubMedPubMedCentral

12.

Kim TJ, Lee JS, Yoon JS, Oh MS, Kim JW, Jung KH, et al. Impact of the dedicated neurointensivists on the outcome in patients with ischemic stroke based on the linked big data for stroke in Korea. J Korean Med Sci. 2020;35(21):e135. https://doi.org/10.3346/jkms.2020.35.e135.CrossRefPubMedPubMedCentral

13.

Lynch EA, Labberton AS, Kim J, Kilkenny MF, Andrew NE, Lannin NA, et al. Out of sight, out of mind: long-term outcomes for people discharged home, to inpatient rehabilitation and to residential aged care after stroke. Disabil Rehabil. 2020:1–7. https://doi.org/10.1080/09638288.2020.1852616.

14.

Overvad TF, Andersen SD, Larsen TB, Lip GYH, Sogaard M, Skjoth F, et al. Incidence and prognostic factors for recurrence of intracerebral hemorrhage in patients with and without atrial fibrillation: a cohort study. Thromb Res. 2020;191:1–8. https://doi.org/10.1016/j.thromres.2020.03.024.CrossRefPubMed

15.

Phan HT, Gall SL, Blizzard CL, Lannin NA, Thrift AG, Anderson CS, et al. Sex differences in care and long-term mortality after stroke: Australian stroke clinical registry. J Womens Health (Larchmt). 2019;28(5):712–20. https://doi.org/10.1089/jwh.2018.7171.CrossRef

16.

Skyrud KD, Vikum E, Hansen TM, Kristoffersen DT, Helgeland J. Hospital variation in 30-day mortality for patients with stroke; the impact of individual and municipal socio-demographic status. J Am Heart Assoc. 2019;8(14):e010148. https://doi.org/10.1161/JAHA.118.010148.CrossRefPubMedPubMedCentral

17.

Vyas MV, Austin PC, Fang J, Laupacis A, Silver FL, Kapral MK. Immigration status, ethnicity, and long-term outcomes following ischemic stroke. Neurology. 2021;20. https://doi.org/10.1212/WNL.0000000000011451.

18.

Yu AYX, Fang J, Kapral MK. One-year home-time and mortality after thrombolysis compared with nontreated patients in a propensity-matched analysis. Stroke. 2019;50(12):3488–93. https://doi.org/10.1161/STROKEAHA.119.026922.CrossRefPubMed

19.

Yu AYX, Austin PC, Rashid M, Fang J, Porter J, Hill MD, et al. Deriving a passive surveillance stroke severity indicator from routinely collected administrative data: the passv indicator. Circ Cardiovasc Qual Outcomes. 2020;13(2):e006269. https://doi.org/10.1161/CIRCOUTCOMES.119.006269.CrossRefPubMed

20.

Yung NCL, Wong CSM, Chan JKN, Or PCF, Chen EYH, Chang WC. Mortality in patients with schizophrenia admitted for incident ischemic stroke: a population-based cohort study. Eur Neuropsychopharmacol. 2020;31:152–7. https://doi.org/10.1016/j.euroneuro.2019.12.107.CrossRefPubMed

21.

• Zhang W, Anderson CS, Kilkenny MF, Kim J, Dewey HM, Andrew NE, et al. Hospital admissions prior to primary intracerebral haemorrhage and relevant factors associated with survival. J Stroke Cerebrovasc Dis. 2020;29(9):105026. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105026. The authors found that stroke severity was associated with a 4-fold greater risk of 180-day mortality among patients with intracerebral hemorrhage.CrossRefPubMed

22.

•• Dalli LL, Kim J, Cadilhac DA, Greenland M, Sanfilippo FM, Andrew NE, et al. Greater adherence to secondary prevention medications improves survival after stroke or transient ischemic attack: a linked registry study. Stroke. 2021;52(11):3569–77. https://doi.org/10.1161/STROKEAHA.120.033133. The authors reported that having a greater adherence within 1 year of hospital discharge, defined as ≥80% proportion of days covered, was associated with improved survival after stroke/TIA.CrossRefPubMed

23.

• Dwyer M, Francis K, Peterson GM, Ford K, Gall S, Phan H, et al. Regional differences in the care and outcomes of acute stroke patients in australia: an observational study using evidence from the Australian Stroke Clinical Registry (AuSCR). BMJ Open. 2021;11(4):e040418. https://doi.org/10.1136/bmjopen-2020-040418. Compared to rural dwellers, urban dwellers more often report extreme problems with mobility (7% vs 5%) and self-care (12% vs 9%).CrossRefPubMedPubMedCentral

24.

•• Burneo JG, Antaya TC, Allen BN, Belisle A, Shariff SZ, Saposnik G. The risk of new-onset epilepsy and refractory epilepsy in older adult stroke survivors. Neurology. 2019;93(6):e568–77. https://doi.org/10.1212/WNL.0000000000007895. It was reported that 1.1% of patients with stroke, aged ≥67 years, developed epilepsy within 2 years of hospital discharge, of whom 46% died within 5 years.CrossRefPubMed

25.

Joundi RA, Saposnik G, Martino R, Fang J, Kapral MK. Timing of direct enteral tube placement and outcomes after acute stroke. J Stroke Cerebrovasc Dis. 2019;28(12):104401. https://doi.org/10.1016/j.jstrokecerebrovasdis.2019.104401.CrossRefPubMed

26.

Freburger JK, Chou A, Euloth T, Matcho B, Bilderback A. Association between use of rehabilitation in the acute care hospital and hospital readmission or mortality in patients with stroke. Arch Phys Med Rehabil. 2021;102(9):1700–7 e4. https://doi.org/10.1016/j.apmr.2021.02.026.

27.

Kuohn LR, Leasure AC, Acosta JN, Vanent K, Murthy SB, Kamel H, et al. Cause of death in spontaneous intracerebral hemorrhage survivors: multistate longitudinal study. Neurology. 2020;95(20):e2736–45. https://doi.org/10.1212/WNL.0000000000010736.CrossRefPubMedPubMedCentral

28.

Meyer AC, Torssander J, Talback M, Modig K. Parents survive longer after stroke than childless individuals: a prospective cohort study of swedes over the age of 65. Eur J Public Health. 2019;29(6):1090–5. https://doi.org/10.1093/eurpub/ckz053.CrossRefPubMedPubMedCentral

29.

•• Gabet A, Grave C, Chatignoux E, Tuppin P, Bejot Y, Olie V. Characteristics, management, and case-fatality of patients hospitalized for stroke with a diagnosis of covid-19 in France. Neuroepidemiology. 2021;55(4):323–30. https://doi.org/10.1159/000516670. It was reported that, among patients hospitalized with stroke, those with concurrent COVID-19 infection had an 85% increased rate of 3-month mortality than those without. This finding was more pronounced in patients with ischemic stroke, with a 2-fold greater rate of 3-month mortality observed among those with concurrent COVID-19 than those without.CrossRefPubMed

30.

•• Richter D, Krogias C, Eyding J, Bartig D, Grau A, Weber R. Comparison of stroke care parameters in acute ischemic stroke patients with and without concurrent COVID-19. A nationwide analysis Neurol Res Pract. 2020;2:48. https://doi.org/10.1186/s42466-020-00095-9. The authors reported that COVID-19 infection was associated with a 2-fold greater risk of 3-month mortality among those with a history of stroke.CrossRefPubMed

31.

Kapral MK, Shah BR, Green ME, Porter J, Griffiths R, Frymire E, et al. Hospital admission for stroke or transient ischemic attack among First Nations people with diabetes in Ontario: a population-based cohort study. CMAJ Open. 2020;8(1):E156–62. https://doi.org/10.9778/cmajo.20190199.CrossRefPubMedPubMedCentral

32.

•• Liao NS, Sidney S, Deosaransingh K, Van Den Eeden SK, Schwartz J, Alexeeff SE. Particulate air pollution and risk of cardiovascular events among adults with a history of stroke or acute myocardial infarction. J Am Heart Assoc. 2021;10(10):e019758. https://doi.org/10.1161/JAHA.120.019758. Exposure to a low-dose particulate matter (PM_2.52.5 <12µg/m³3) over a year increases the risk of 5-year cardiovascular mortality by 2-fold among patients with a history stroke.CrossRefPubMedPubMedCentral

33.

Brunner-La Rocca HP, Peden CJ, Soong J, Holman PA, Bogdanovskaya M, Barclay L. Reasons for readmission after hospital discharge in patients with chronic diseases-information from an international dataset. PLoS ONE. 2020;15(6):e0233457. https://doi.org/10.1371/journal.pone.0233457.CrossRefPubMedPubMedCentral

34.

•• Kapral MK, Austin PC, Jeyakumar G, Hall R, Chu A, Khan AM, et al. Rural-urban differences in stroke risk factors, incidence, and mortality in people with and without prior stroke. Circ Cardiovasc Qual Outcomes. 2019;12(2):e004973. https://doi.org/10.1161/CIRCOUTCOMES.118.004973. In this study, the authors provided evidence on regional differences in mortality post-stroke. They found that dwelling in a rural area (vs. urban area) was associated with increased risk of mortality among Canadian residents.CrossRefPubMed

35.

•• Kilkenny MF, Phan HT, Lindley RI, Kim J, Lopez D, Dalli LL, et al. Utility of the hospital frailty risk score derived from administrative data and the association with stroke outcomes. Stroke. 2021;52(9):2874–81. https://doi.org/10.1161/STROKEAHA.120.033648. The Frailty score, an emerging surrogate measure of stroke outcome, predicted multiple outcomes after stroke, including 30-day mortality, 90-day readmissions, and health-related quality of life.CrossRefPubMed

36.

Yu AYX, Maclagan LC, Diong C, Austin PC, Kapral MK, Swartz RH, et al. Sex differences in care need and survival in patients admitted to nursing home poststroke. Can J Neurol Sci. 2020;47(2):153–9. https://doi.org/10.1017/cjn.2019.335.CrossRefPubMed

37.

Richter D, Eyding J, Weber R, Bartig D, Grau A, Hacke W, et al. Analysis of nationwide stroke patient care in times of COVID-19 pandemic in Germany. Stroke. 2021;52(2):716–21. https://doi.org/10.1161/STROKEAHA.120.033160.CrossRefPubMed

38.

Rumball-Smith J, Hider P. The validity of readmission rate as a marker of the quality of hospital care, and a recommendation for its definition. N Z Med J. 2009;122(1289):63–70.

39.

Andrew NE, Kilkenny MF, Sundararajan V, Kim J, Faux SG, Thrift AG, et al. Hospital presentations in long-term survivors of stroke: causes and associated factors in a linked data study. Stroke. 2020;51(12):3673–80. https://doi.org/10.1161/STROKEAHA.120.030656.CrossRefPubMed

40.

Kilkenny MF, Dalli LL, Kim J, Sundararajan V, Andrew NE, Dewey HM, et al. Factors associated with 90-day readmission after stroke or transient ischemic attack: linked data from the Australian Stroke Clinical Registry. Stroke. 2020;51(2):571–8. https://doi.org/10.1161/STROKEAHA.119.026133.CrossRefPubMed

41.

•• Mosalski S, Shiner CT, Lannin NA, Cadilhac DA, Faux SG, Kim J, et al. Increased relative functional gain and improved stroke outcomes: a linked registry study of the impact of rehabilitation. J Stroke Cerebrovasc Dis. 2021;30(10):106015. https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.Patients with greater relative functional gain during inpatient rehabilitation following acute stroke/TIA were more than 10 times more likely to be independent at 90–180 days after stroke/TIA.CrossRefPubMed

42.

Daras LC, Deutsch A, Ingber MJ, Hefele JG, Perloff J. Inpatient rehabilitation facilities’ hospital readmission rates for Medicare beneficiaries treated following a stroke. Top Stroke Rehabil. 2021;28(1):61–71. https://doi.org/10.1080/10749357.2020.1771927.CrossRefPubMed

43.

Raja A, Trivedi PD, Dhamoon MS. Discharge against medical advice among neurological patients: characteristics and outcomes. Health Serv Res. 2020;55(5):681–9. https://doi.org/10.1111/1475-6773.13306.CrossRefPubMedPubMedCentral

44.

Stroke Foundation. Secondary prevention. In: Clinical guidelines for stroke management. Stroke Foundation. 2021. https://informme.org.au/guidelines/clinical-guidelines-for-stroke-management. Accessed 15 Sep 2021.

45.

Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344–418. https://doi.org/10.1161/STR.0000000000000211.CrossRefPubMed

46.

•• Dalli LL, Kim J, Thrift AG, Andrew NE, Sanfilippo FM, Lopez D, et al. Patterns of use and discontinuation of secondary prevention medications after stroke. Neurology. 2021;96(1):e30–41. https://doi.org/10.1212/WNL.The authors found that up to one-third of patients with stroke discontinue their medication within 1 year of discharge.CrossRefPubMed

47.

Barrett E, Paige E, Welsh J, Korda RJ, Joshy G, Martin M, et al. Differences between men and women in the use of preventive medications following a major cardiovascular event: Australian prospective cohort study. Preventive medicine reports. 2021;22:101342. https://doi.org/10.1016/j.pmedr.2021.101342.CrossRefPubMedPubMedCentral

48.

Welsh J, Paige E, Banks E, Joshy G, Brieger D, Korda RJ. Psychological distress and medication use for secondary prevention of cardiovascular events: evidence from a large-scale population-based cohort study. J Psychosom Res. 2019;124:109748. https://doi.org/10.1016/j.jpsychores.2019.109748.CrossRefPubMed

49.

Brown AW, Lee M, Lennon RJ, Niewczyk PM. Functional performance and discharge setting predict outcomes 3 months after rehabilitation hospitalization for stroke. J Stroke Cerebrovasc Dis. 2020;29(5):104746. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104746.CrossRefPubMed

50.

Holodinsky JK, Yu AYX, Kapral MK, Austin PC. Comparing regression modeling strategies for predicting hometime. BMC Med Res Methodol. 2021;21(1):138. https://doi.org/10.1186/s12874-021-01331-9.CrossRefPubMedPubMedCentral

51.

• Phan HT, Gall SL, Blizzard CL, Lannin NA, Thrift AG, Anderson CS, et al. Sex differences in quality of life after stroke were explained by patient factors, not clinical care: evidence from the Australian Stroke Clinical Registry. Eur J Neurol. 2021;28(2):469–78. https://doi.org/10.1111/ene.The authors found no sex difference in the overall post-stroke/TIA HRQoL. However, they found that females were 8–16% more likely to report problems related to usual activities, anxiety/depression, or pain/discomfort.CrossRefPubMed

52.

Balestroni G, Bertolotti G. [euroqol-5d (eq-5d): An instrument for measuring quality of life. Monaldi Arch Chest Dis. 2012;78(3):155–9. https://doi.org/10.4081/monaldi.2012.121.CrossRefPubMed

53.

Luengo-Fernandez R, Violato M, Candio P, Leal J. Economic burden of stroke across Europe: a population-based cost analysis. Eur Stroke J. 2020;5(1):17–25. https://doi.org/10.1177/2396987319883160.CrossRefPubMed

54.

Stroke Foundation. The economic impact of stroke in Australia, Deloitte Access Economics. 2020. https://strokefoundation.org.au/News/2020/11/04/02/57/No%20Postcode%20Untouched. Accessed 15 Sep 2021.

55.

Griffith LE, Gruneir A, Fisher K, Panjwani D, Gafni A, Patterson C, et al. Insights on multimorbidity and associated health service use and costs from three population-based studies of older adults in Ontario with diabetes, dementia and stroke. BMC Health Serv Res. 2019;19(1):313. https://doi.org/10.1186/s12913-019-4149-3.CrossRefPubMedPubMedCentral

56.

Qiao D, Zhang Y, Rehman AU, Khosravi MR. Big data-enabled analysis of DRGs-based payment on stroke patients in Jiaozuo. China J Healthc Eng. 2020;2020:6690019. https://doi.org/10.1155/2020/6690019.CrossRefPubMed

57.

Hoang MT, Kareholt I, von Euler M, Jonsson L, von Koch L, Eriksdotter M, et al. Costs of inpatient rehabilitation for ischemic stroke in patients with dementia: a cohort Swedish register-based study. J Alzheimers Dis. 2020;73(3):967–79. https://doi.org/10.3233/JAD-190749.CrossRefPubMedPubMedCentral

58.

Rozjabek HM, Coleman CI, Ashton V, Laliberte F, Oyefesobi P, Lejeune D, et al. Healthcare costs of stroke and major bleeding in patients with atrial fibrillation treated with non-vitamin k antagonist oral anticoagulants. J Med Econ. 2019;22(8):751–9. https://doi.org/10.1080/13696998.2019.1603156.CrossRefPubMed

59.

Wang W, Kiik M, Peek N, Curcin V, Marshall IJ, Rudd AG, et al. A systematic review of machine learning models for predicting outcomes of stroke with structured data. PLoS ONE. 2020;15(6):e0234722. https://doi.org/10.1371/journal.pone.0234722.CrossRefPubMedPubMedCentral

60.

Darabi N, Hosseinichimeh N, Noto A, Zand R, Abedi V. Machine learning-enabled 30-day readmission model for stroke patients. Front Neurol. 2021;12:638267. https://doi.org/10.3389/fneur.2021.638267.CrossRefPubMedPubMedCentral

61.

Drozdowska BA, Singh S, Quinn TJ. Thinking about the future: a review of prognostic scales used in acute stroke. Front Neurol. 2019;10:274. https://doi.org/10.3389/fneur.2019.00274.CrossRefPubMedPubMedCentral

62.

•• Abedi V, Avula V, Razavi SM, Bavishi S, Chaudhary D, Shahjouei S, et al. Predicting short and long-term mortality after acute ischemic stroke using EHR. J Neurol Sci. 2021;427:117560. https://doi.org/10.1016/j.jns.2021.Machine learning algorithms corroborated that age, hemoglobin, and body mass index are the top three most important predictors of mortality within 24 months after stroke, in the absence of stroke severity, and that laboratory-based variables rank higher than comorbidities (e.g., HbA1C vs. presence of history of diabetes) in predicting stroke outcomes.CrossRefPubMed

63.

Heo TS, Kim YS, Choi JM, Jeong YS, Seo SY, Lee JH, et al. Prediction of stroke outcome using natural language processing-based machine learning of radiology report of brain MRI. J Pers Med. 2020;10(4). https://doi.org/10.3390/jpm10040286.

64.

Lineback CM, Garg R, Oh E, Naidech AM, Holl JL, Prabhakaran S. Prediction of 30-day readmission after stroke using machine learning and natural language processing. Frontiers in Neurology. 2021;12:1069

65.

Selles RW, Andrinopoulou ER, Nijland RH, van der Vliet R, Slaman J, van Wegen EE, et al. Computerised patient-specific prediction of the recovery profile of upper limb capacity within stroke services: the next step. J Neurol Neurosurg Psychiatry. 2021;92(6):574–81. https://doi.org/10.1136/jnnp-2020-324637.CrossRef

66.

Ge Y, Wang Q, Wang L, Wu H, Peng C, Wang J, et al. Predicting post-stroke pneumonia using deep neural network approaches. Int J Med Inform. 2019;132:103986. https://doi.org/10.1016/j.ijmedinf.2019.103986.CrossRefPubMed

67.

Lienhart AM, Kramer D, Jauk S, Gugatschka M, Leodolter W, Schlegl T. Multivariable risk prediction of dysphagia in hospitalized patients using machine learning. Stud Health Technol Inform. 2020;271:31–8. https://doi.org/10.3233/SHTI200071.CrossRefPubMed

68.

Kogan E, Twyman K, Heap J, Milentijevic D, Lin JH, Alberts M. Assessing stroke severity using electronic health record data: a machine learning approach. BMC Med Inform Decis Mak. 2020;20(1):8. https://doi.org/10.1186/s12911-019-1010-x.CrossRefPubMedPubMedCentral

69.

Bacchi S, Oakden-Rayner L, Menon DK, Jannes J, Kleinig T, Koblar S. Stroke prognostication for discharge planning with machine learning: a derivation study. J Clin Neurosci. 2020;79:100–3. https://doi.org/10.1016/j.jocn.2020.07.046.CrossRefPubMed

70.

Patel PD, Salwi S, Liles C, Mistry AM, Mistry EA, Fusco MR, et al. Creation and validation of a stroke scale to increase utility of national inpatient sample administrative data for clinical stroke research. J Stroke Cerebrovasc Dis. 2021;30(4):105658. https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105658.CrossRefPubMed

71.

Bustamante A, Garcia-Berrocoso T, Rodriguez N, Llombart V, Ribo M, Molina C, et al. Ischemic stroke outcome: a review of the influence of post-stroke complications within the different scenarios of stroke care. Eur J Intern Med. 2016;29:9–21. https://doi.org/10.1016/j.ejim.2015.11.030.CrossRefPubMed

72.

Cadilhac DA, Kilkenny MF, Levi CR, Lannin NA, Thrift AG, Kim J, et al. Risk-adjusted hospital mortality rates for stroke: evidence from the Australian Stroke Clinical Registry (AuSCR). Med J Aust. 2017;206(8):345–50. https://doi.org/10.5694/mja16.00525.CrossRefPubMed

73.

•• Smith EE, Fang J, Alibhai SM, Cram P, Cheung AM, Casaubon LK, et al. Derivation and external validation of a scoring system for predicting fracture risk after ischemic stroke in a Canadian cohort. JAMA Neurol. 2019;76(8):925–31. https://doi.org/10.1001/jamaneurol.2019.1114. The authors provided evidence that the FRAC-Stroke score can be used to identify patients at elevated risk of low-trauma fracture after stroke who could benefit from pharmacotherapy or bone densitometry screening.CrossRefPubMedPubMedCentral

74.

Gattellari M, Goumas C, Jalaludin B, Worthington J. Measuring stroke outcomes for 74 501 patients using linked administrative data: system-wide estimates and validation of ‘home-time’ as a surrogate measure of functional status. Int J Clin Pract. 2020;74(6):e13484. https://doi.org/10.1111/ijcp.13484.CrossRefPubMed

75.

Sung SF, Su CC, Hsieh CY, Cheng CL, Chen CH, Lin HJ, et al. Home-time as a surrogate measure for functional outcome after stroke: a validation study. Clin Epidemiol. 2020;12:617–24. https://doi.org/10.2147/CLEP.S245817.CrossRefPubMedPubMedCentral

76.

McDermid I, Barber M, Dennis M, Langhorne P, Macleod MJ, McAlpine CH, et al. Home-time is a feasible and valid stroke outcome measure in national datasets. Stroke. 2019;50(5):1282–5. https://doi.org/10.1161/STROKEAHA.118.023916.CrossRefPubMed

77.

Yu AYX, Fang J, Porter J, Austin PC, Smith EE, Kapral MK. Hospital-based cohort study to determine the association between home-time and disability after stroke by age, sex, stroke type and study year in Canada. BMJ Open. 2019;9(11):e031379. https://doi.org/10.1136/bmjopen-2019-031379.CrossRefPubMedPubMedCentral

78.

•• Ung D, Dalli LL, Lopez D, Sanfilippo FM, Kim J, Andrew NE, et al. Assuming one dose per day yields a similar estimate of medication adherence in patients with stroke: an exploratory analysis using linked registry data. Br J Clin Pharmacol. 2021;87(3):1089–97. https://doi.org/10.1111/bcp.It was reported that assuming a daily dose of one tablet per day yields a similar estimate of medication adherence after stroke/TIA compared to other more complicated methods of estimating doses.CrossRefPubMed

Title: The Allure of Big Data to Improve Stroke Outcomes: Review of Current Literature
Authors: Muideen T. Olaiya
Nita Sodhi-Berry
Lachlan L. Dalli
Kiran Bam
Amanda G. Thrift
Judith M. Katzenellenbogen
Lee Nedkoff
Joosup Kim
Monique F. Kilkenny
Publication date: 01-03-2022
Publisher: Springer US
Keyword: Stroke
Published in: Current Neurology and Neuroscience Reports / Issue 3/2022
Print ISSN: 1528-4042
Electronic ISSN: 1534-6293
DOI: https://doi.org/10.1007/s11910-022-01180-z

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

The Allure of Big Data to Improve Stroke Outcomes: Review of Current Literature

Abstract

Purpose of Review

Recent Findings

Summary

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 3/2022

Neuromodulation Treatments for Mild Traumatic Brain Injury and Post-concussive Symptoms

Recent Advances in the Impact of Infection and Inflammation on Stroke Risk and Outcomes

Gamified Neurorehabilitation Strategies for Post-stroke Motor Recovery: Challenges and Advantages

Essential Tremor—Do We Have Better Therapeutics? A Review of Recent Advances and Future Directions

Visual Snow: Updates on Pathology

Neuro-Visual and Vestibular Manifestations of Concussion and Mild TBI